Edition:
United States

Search Results  for '600521.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Zhejiang Huahai Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

27 Aug 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Zhejiang Huahai Pharmaceutical Co Ltd (600521-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

28 Aug 2016 Thomson Reuters Stock Report 11 $25.00

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) - Financial and Strategic SWOT Analysis Review

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) - Financial and Strategic SWOT Analysis Review Summary Zhejiang Huahai Phar...

05 Aug 2016 GlobalData 51 $300.00

Zhejiang Huahai Pharmaceutical Co., Ltd.: Downgraded to Average

19 Jul 2016 Sadif Analytics Prime 3 $10.00

Will Zhejiang Huahai Pharmaceutical Co., Ltd. Deliver Long-Term Returns?

23 Jun 2016 Sadif Analytics Prime 12 $25.00

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) - Financial and Strategic SWOT Analysis Review

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) - Financial and Strategic SWOT Analysis Review Summary Zhejiang Huahai Phar...

09 Jun 2016 GlobalData 51 $300.00

Zhejiang Huahai Pharmaceutical Co., Ltd.: Upgraded to Above Average

16 May 2016 Sadif Analytics Prime 3 $10.00

Thomson Reuters Stock Report - Zhejiang Huahai Pharmaceutical Co Ltd (600521-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00

Is Now the Time to Buy Zhejiang Huahai Pharmaceutical Co., Ltd.?

24 Mar 2016 Sadif Analytics Prime 12 $25.00

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) - Financial and Strategic SWOT Analysis Review

Zhejiang Huahai Pharmaceutical Co., Ltd. (600521) - Financial and Strategic SWOT Analysis Review Summary Zhejiang Huahai Phar...

07 Mar 2016 GlobalData 52 $300.00